Cor Vasa 2017, 59(4):e416-e417 | DOI: 10.1016/j.crvasa.2017.03.012

The authors of lipid guidelines are at odds with their own recommendations

Richard Češka^*, Michal Vrablík

Centrum preventivní kardiologie, III. interní klinika, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha, Česká republika

In the era of evidence-based medicine, diagnostic and treatment guidelines prepared by professional societies, as well as expert opinions, constitute substantial guidance for practicing physicians. However, in a joint ESC/EAS publication, "Task Force consensus statement on proprotein convertase subtilisin/Kexin Type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk",' has caught a significant number of practicing physicians off guard and left them perplexed. Physicians are obliged to treat patients in accordance with the latest scientific findings, which those attempting to form legal interpretations often confuse as treatment according to guidelines. Therefore, an expert opinion should respect professional viewpoints and strive to maximize and accommodate all the various patients who stand to benefit from the use of a particular treatment, not just those patients most often studied.

Keywords: Cardiovascular risk; Familial hypercholesterolemia; LDL-C; Lp, a, ; PCSK9 inhibitors; Target levels of LDL-C

Received: February 2, 2017; Accepted: March 24, 2017; Published: August 1, 2017  Show citation